Improving osteoporosis screening, risk assessment, diagnosis, and treatment initiation: Role of the health-system pharmacist in closing the gap

MacLaughlin, Eric J.
April 2010
American Journal of Health-System Pharmacy;Apr2010 Supplement 3, Vol. 67, pS4
Academic Journal
The article focuses on the epidemiology of osteoporosis-related fractures in the U.S. and the novel risk assessment approaches and treatment decision. It states that a dual-energy X-ray absorptiometry (DXA) is use to assess bone mineral density (BMD) to diagnose osteoporosis. It mentions that the National Osteoporosis Foundation (NOF) publication incorporates BMD testing and treatment guidelines to cut fracture risk and a fracture risk assessment tool from the World Health Organization (WHO).


Related Articles

  • FRAX(r) version 3.6 released with 5 new country models.  // Biomedical Market Newsletter;5/7/2012, Vol. 21, p1 

    The article informs that the World Health Organization (WHO) has launched version 3.6 of its Fracture Risk Assessment Tool, FRAX with new country models for Chile, Greece, Indonesia, Ireland and Lithuania and Greek as an additional language option.

  • The distribution of FRAX-based probabilities in women from Japan. Kanis, John; Johansson, Helena; Odén, Anders; McCloskey, Eugene // Journal of Bone & Mineral Metabolism;Nov2012, Vol. 30 Issue 6, p700 

    New assessment guidelines for osteoporosis in Japan include the use of the WHO risk assessment tool (FRAX) that computes the 10-year probability of fracture. The aim of this study was to determine the distribution of fracture probabilities and to assess the impact of probability-based...

  • Diagnosis and treatment of osteoporosis. Ye-Soo Park // Journal of the Korean Medical Association / Taehan Uisa Hyophoe ;Nov2012, Vol. 55 Issue 11, p1083 

    Osteoporosis is a common bone disease in postmenopausal women that leads to an increased risk of fracture. In osteoporosis, the bone mineral density (BMD) is reduced, and bone micro- and macroarchitecture deteriorates. Osteoporosis is defined by the World Health Organization as a BMD of 2.5...

  • Osteoporosis - time to downgrade? Hrycaj, Paweł // Rheumatology / Reumatologia;2015, Vol. 53 Issue 3, p117 

    The author reflects on the present concept of osteoporosis which is an artificial construct purely based on statistical considerations and often leads to paradoxical situations. Topics cited include how patients with T-score nearing the -2.5 T-score threshold has and does not have osteoporosis,...

  • FRAX(r) version 3.6 released with 5 new country models.  // Biomedical Market Newsletter;5/25/2012, Vol. 21, p1 

    The article informs that the Fracture Risk Assessment Tool version 3.6 developed by the World Health Organization has been released in additional countries including Chile, Greece and Indonesia.

  • FRAX fracture risk in women with a recent fracture of the distal forearm: agreement between assessments with and without bone mineral density and impact of measurement side in the individual patient. Egsmose, Emilie; Birkvig, Mette; Buhl, Thora; Madsen, Ole // Clinical Rheumatology;Jul2015, Vol. 34 Issue 7, p1265 

    The Fracture Risk Assessment Tool (FRAX) has been developed by the World Health Organization to evaluate the 10-year risk of a hip fracture and a major osteoporotic fracture. We examined the agreement between fracture risk calculated with and without femoral neck bone mineral density (BMD) in...

  • Recent Advances in Management of Cancer Treatment-induced Bone Loss (CTIBL) in Patients with Breast or Prostate Cancer. Soo Hyun Kim; Hong Seongbin Kim; Song Youngkyu Kim; Song Hosook Kim // Asian Oncology Nursing;Sep2013, Vol. 13 Issue 3, p103 

    Purpose: Bone loss resulting from cancer treatment is an emerging problem among cancer survivors. However, the mechanism and treatment of cancer treatment-induced bone loss (CTIBL) is not fully understood. The purpose of this article was to review the recent advances in CTIBL. Methods: A...

  • Using FRAX to assess the risk that an older person will suffer a fragility fracture. Vernon, Sue; King, Rachel // British Journal of Community Nursing;Nov2011, Vol. 16 Issue 11, p534 

    A challenge of planning for local health services is how to prevent the effects of diseases of older age in order to reduce individual suffering and also wider economic costs to society. This article discusses FRAX® (Fracture Risk Assessment), a computer-based algorithm that allows 10-year...

  • Overdiagnosis of bone fragility in the quest to prevent hip fracture. Järvinen, Teppo L. N.; Michaëlsson, Karl; Jokihaara, Jarkko; Collins, Gary S.; Perry, Thomas L.; Mintzes, Barbara; Musini, Vijaya; Erviti, Juan; Gorricho, Javier; Wright, James M.; Sievänen, Harri // BMJ: British Medical Journal;5/30/2015, Vol. 350 Issue 8010, ph2088 

    The author presents his views on the insufficiency of evidence for stratifying risk of fracture and subsequent drug therapy to prevent hip fracture to warrant current approach which assumes the link between bone fragility and hip fracture. Topics include the association between hip fractures and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics